Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's DiseaseParkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathyRecruitingPhase 12026-03-20NCT07310264

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Vertero Therapeutics2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Center for Human Drug ResearchLeidenNetherlands2